» Articles » PMID: 26083048

Progesterone and Vitamin D Combination Therapy Modulates Inflammatory Response After Traumatic Brain Injury

Overview
Journal Brain Inj
Publisher Informa Healthcare
Specialty Neurology
Date 2015 Jun 18
PMID 26083048
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Inflammation is an important component of the response to traumatic brain injury (TBI). Progesterone has been shown to inhibit neuroinflammation following (TBI) and may do so through Toll-like receptor (TLR)-mediated pathways. In vitro studies indicate that 1,25-dihydroxyvitamin D(3) (VDH) may also modulate the inflammatory response through the TLR4 pathway. This study tested the hypothesis that PROG and VDH would exert additive and synergistic neuroprotective effects compared with individual treatment by modulating TLR4/NF-κB-mediated inflammation pathways after TBI in rats.

Research Design And Methods: Bilateral medial frontal cortical impact injury was induced in young adult Sprague-Dawley rats. Progesterone (i.p., 16 mg kg body weight) and VDH (1 µg kg body weight) were injected separately or combined at 1 and 6 hours after surgery. Rats were killed 24 hours post-surgery and peri-contusional brain tissue harvested for immunostaining and protein measurement.

Results: TLR4, phosphorylation of NF-κB, neuronal loss and astrocyte activation were significantly reduced with combination treatment after TBI compared to each agent given individually.

Conclusions: At 24 hours after TBI, combination therapy shows greater efficacy in reducing neuroinflammation compared to progesterone and VDH given separately, and does so by modulating the TLR4/NF-κB signalling pathway.

Citing Articles

Vitamin D in Central Nervous System: Implications for Neurological Disorders.

Sailike B, Onzhanova Z, Akbay B, Tokay T, Molnar F Int J Mol Sci. 2024; 25(14).

PMID: 39063051 PMC: 11277055. DOI: 10.3390/ijms25147809.


Thiamine use is associated with better outcomes for traumatic brain injury patients.

Wang R, Zeng Y, Xu J, He M Front Nutr. 2024; 11:1362817.

PMID: 39036489 PMC: 11257909. DOI: 10.3389/fnut.2024.1362817.


An updated systematic review of neuroprotective agents in the treatment of spinal cord injury.

Serag I, Abouzid M, Elmoghazy A, Sarhan K, Alsaad S, Mohamed R Neurosurg Rev. 2024; 47(1):132.

PMID: 38546884 DOI: 10.1007/s10143-024-02372-6.


Pattern-recognition receptors in endometriosis: A narrative review.

Guo B, Chen J, Zhang J, Fang Y, Liu X, Zhang J Front Immunol. 2023; 14:1161606.

PMID: 37033937 PMC: 10076794. DOI: 10.3389/fimmu.2023.1161606.


Multi-Mechanistic Approaches to the Treatment of Traumatic Brain Injury: A Review.

Lynch D, Narayan R, Li C J Clin Med. 2023; 12(6).

PMID: 36983181 PMC: 10052098. DOI: 10.3390/jcm12062179.


References
1.
Sinz E, Kochanek P, Dixon C, Clark R, Carcillo J, Schiding J . Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest. 1999; 104(5):647-56. PMC: 408535. DOI: 10.1172/JCI6670. View

2.
Pahl H . Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999; 18(49):6853-66. DOI: 10.1038/sj.onc.1203239. View

3.
Strauss K, Barbe M, Marshall R, Raghupathi R, Mehta S, Narayan R . Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. J Neurotrauma. 2000; 17(8):695-711. PMC: 1456323. DOI: 10.1089/089771500415436. View

4.
Surh Y, Chun K, Cha H, Han S, Keum Y, Park K . Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001; 480-481:243-68. DOI: 10.1016/s0027-5107(01)00183-x. View

5.
Morganti-Kossmann M, Rancan M, Stahel P, Kossmann T . Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care. 2002; 8(2):101-5. DOI: 10.1097/00075198-200204000-00002. View